Cash Flows from Operating Activities |
Net income |
711M |
Adjustments to reconcile net income to net cash provided by operating activities: |
Depreciation, amortization, and decommissioning |
2.09B |
Allowance for equity funds used during construction |
-84M |
Deferred income taxes and tax credits, net |
644M |
Other |
Effect of changes in operating assets and liabilities: |
Accounts receivable |
-546M |
Inventories |
-38M |
Accounts payable |
189M |
Disputed claims and customer refunds |
Income taxes receivable/payable |
-63M |
Other current assets |
Other current liabilities |
Regulatory assets, liabilities, and balancing accounts, net |
-634M |
Other changes in noncurrent assets and liabilities |
Net cash provided by (used in) operating activities |
3.25B |
Cash Flows from Investing Activities |
Capital expenditures |
-4.13B |
Decrease in restricted cash |
66M |
Proceeds from sales and maturities of nuclear decommissioning trust investments |
Purchases of nuclear decommissioning trust investments |
Other |
10M |
Net cash provided by (used in) investing activities |
-4.08B |
Cash Flows from Financing Activities |
Borrowings under revolving credit facilities |
Repayments under revolving credit facilities |
Net issuances of commercial paper, net of discount of $3 in 2010 and 2009, and $11 in 2008 |
Proceeds from issuance of short-term debt, net of issuance costs of $1 in 2010 and 2009 |
250M |
Proceeds from issuance of long-term debt, net of premium, discount, and issuance costs of $23 in 2010, $29 in 2009, and $19 in 2008 |
594M |
Short-term debt matured |
0 |
Long-term debt matured or repurchased |
Energy recovery bonds matured |
Common stock issued |
727M |
Common stock dividends paid |
-678M |
Other |
18M |
Net cash provided by (used in) financing activities |
783M |
Net change in cash and cash equivalents |
-52M |
Cash and cash equivalents at January 1 |
123M |
Cash and cash equivalents at December 31 |
71M |
Cash received (paid) for: |
Interest, net of amounts capitalized |
-611M |
Income taxes, net |
154M |
Supplemental disclosures of noncash investing and financing activities |
Common stock dividends declared but not yet paid |
Capital expenditures financed through accounts payable |
325M |
Noncash common stock issuances |